Efficacy and Tolerability of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder in Adults

Author： Santosh Paramala J.   Sattar Sanjida  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.25, Iss.9, 2011-09, pp. : 737-763

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of Methylphenidate for Adults with Attention-Deficit Hyperactivity Disorder: A Meta-Regression Analysis

By Castells Xavier   >   Rigau David  

CNS Drugs, Vol. 25, Iss. 2, 2011-02 ,pp. : 157-169

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder: A Systematic Literature Review

By Wu Eric Q.  

CNS Drugs, Vol. 26, Iss. 7, 2012-07 ,pp. : 581-600

Adis International

Access to resources Recommend Favorite

Adverse Effects of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder: Epidemiology, Prevention and Management

By Graham Johnny   Coghill David  

CNS Drugs, Vol. 22, Iss. 3, 2008-01 ,pp. : 213-237

Adis International

Access to resources Recommend Favorite

Drug Therapy for Adults with Attention-Deficit Hyperactivity Disorder

By Wilens T.E.  

Drugs, Vol. 63, Iss. 22, 2003-01 ,pp. : 2395-2411

Adis International

Access to resources Recommend Favorite

Spotlight on Atomoxetine in Adults with Attention-Deficit Hyperactivity Disorder

By Simpson D.   Plosker G.L.  

CNS Drugs, Vol. 18, Iss. 6, 2004-01 ,pp. : 397-401

Adis International

Access to resources Recommend Favorite